P. Johnson

发表

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy.

J. von Pawel, U. Gatzemeier, A. Depierre, 1993, European journal of cancer.

Age-related radical-induced DNA damage is linked to prostate cancer.

N. Polissar, T. Wheeler, D. C. Malins, 2001, Cancer research.

Mechanisms of local immunosuppression in cutaneous melanoma

Penny A. Johnson, I. Cree, M. Jager, 2007, British Journal of Cancer.

Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial

P. Sasieni, C. Clarke, R. Neal, 2022, Cancers.

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy

I. Cree, L. Knight, S. Glaysher, 2010, British Journal of Cancer.

Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.

D. Weaver, A. Bhushan, M. Rincón, 2001, Cancer research.

Targeting EGFR and PI3K pathways in ovarian cancer

I. Cree, C. Torrance, S. Glaysher, 2012, British Journal of Cancer.

Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: a long-term follow-up.

J. von Pawel, U. Gatzemeier, A. Depierre, 1995, European journal of cancer.

Sister chromatid exchange: variation by age, sex, smoking, and breast cancer status.

D. Bishop, D. Timothy Bishop, P. Johnson, 1983, Cancer genetics and cytogenetics.

CAR ENGINEERED NK-92 CELLS: AN OFF-THE-SHELF CELLULAR THERAPEUTIC FOR TARGETED ELIMINATION OF PROSTATE CANCER CELLS VIVO

P. Johnson, R. Edmondson, M. Price, 2020 .

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

M. Highley, T. Meyer, A. Maraveyas, 2009, British Journal of Cancer.